Cargando…
Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested.
Autores principales: | Chepurnov, A. A., Kazachinskaya, E. I., Kazachkova, E. A., Sharshov, K. A., Kononova, Yu. V., Shelemba, A. A., Alekseev, A. Yu., Gulyeva, M. A., Voevoda, M. I., Shestopalov, A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596366/ https://www.ncbi.nlm.nih.gov/pubmed/34787781 http://dx.doi.org/10.1007/s10517-021-05329-7 |
Ejemplares similares
-
Cell and Organism Technologies for Assessment of the SARS-CoV-2 Infectivity in Fluid Environment
por: Shelemba, A. A., et al.
Publicado: (2022) -
Genetic characterization of an H2N2 influenza virus isolated from a muskrat
in Western Siberia
por: GULYAEVA, Marina, et al.
Publicado: (2017) -
Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non‐viral co‐infection
por: Cordero, E., et al.
Publicado: (2011) -
Evaluation of viral co‐infections in hospitalized and non‐hospitalized children with respiratory infections using microarrays
por: Kouni, S., et al.
Publicado: (2012) -
Exosome Biogenesis and Biological Function in Response to Viral Infections
por: Crenshaw, Brennetta J., et al.
Publicado: (2018)